Citations

Clear

16280 citation(s) found for "Yu, David".

Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
Rinaldo, Piero, Rhead, William J., Tian, Liqun, Millington, David S., Vockley, Jerry , Hamm, Doug A., Brix, Amy E., Lindsey, J. Russell, Pinkert, Carl A. , O’Brien, William E., Kurtz, David M. , Wood, Philip A.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 95 | Issue: 26 | Pages: 15592-15597

10.1073/pnas.95.26.15592 | PMID 9861014 Get It

Abnormalities of fatty acid metabolism are recognized to play a significant role in human disease, but the mechanisms remain poorly understood. Long-chain acyl-CoA dehydrogenase (LCAD) catalyzes the initial step in mitochondrial fatty acid oxidation (FAO). We produced a mouse model of LCAD deficiency with severely impaired FAO. Matings between LCAD +/− mice yielded an abnormally low number of LCAD +/− and −/− offspring, indicating frequent gestational loss. LCAD −/− mice that reached birth appeared normal, but had severely reduced fasting tolerance with hepatic and cardiac lipidosis, hypoglycemia, elevated serum free fatty acids, and nonketotic dicarboxylic aciduria. Approximately 10% of adult LCAD −/− males developed cardiomyopathy, and sudden death was observed in 4 of 75 LCAD −/− mice. These results demonstrate the crucial roles of mitochondrial FAO and LCAD in vivo .
Incomplete endoplasmic reticulum (ER) retention in immature thymocytes as revealed by surface expression of “ER-resident” molecular chaperones
Wiest, David L. , Kreibich, Gert, McKean, D J, Singer, Alfred , Bhandoola, Avinash , Punt, Jennifer A.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 94 | Issue: 5 | Pages: 1884-1889

10.1073/pnas.94.5.1884 | PMID 9050874 Get It

The folding and assembly of nascent proteins in the endoplasmic reticulum (ER) is assisted by molecular chaperones that are themselves retained within the ER. We now report that a number of different ER proteins, including molecular chaperones, are selectively expressed on the surface of immature thymocytes, but their surface expression is extinguished upon further differentiation. Escape from the ER is only possible for newly synthesized ER proteins before they become permanently retained. Thus, the cellular process of ER retention is incomplete in immature thymocytes and provides an explanation for surface expression of partial receptor complexes that transduce differentiative signals during thymic development.
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, Juliette, Soeller, Walter C., Roche, Patrick C. , Nelson, R T, Torchia, Anthony J., Kreutter, David K. , Butler, Peter C.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 93 | Issue: 14 | Pages: 7283-7288

10.1073/pnas.93.14.7283 | PMID 8692984 Get It

The islet in non-insulin-dependent diabetes mellitus (NIDDM) is characterized by loss of beta cells and large local deposits of amyloid derived from the 37-amino acid protein, islet amyloid polypeptide (IAPP). We have hypothesized that IAPP amyloid forms intracellularly causing beta-cell destruction under conditions of high rates of expression. To test this we developed a homozygous transgenic mouse model with high rates of expression of human IAPP. Male transgenic mice spontaneously developed diabetes mellitus by 8 weeks of age, which was associated with selective beta-cell death and impaired insulin secretion. Small intra- and extracellular amorphous IAPP aggregates were present in islets of transgenic mice during the development of diabetes mellitus. However, IAPP derived amyloid deposits were found in only a minority of islets at approximately 20 weeks of age, notably after development of diabetes mellitus in male transgenic mice. Approximately 20% of female transgenic mice spontaneously developed diabetes mellitus at 30+ weeks of age, when beta-cell degeneration and both amorphous and amyloid deposits of IAPP were present. We conclude that overexpression of human IAPP causes beta-cell death, impaired insulin secretion, and diabetes mellitus. Large deposits of IAPP derived amyloid do not appear to be important in this cytotoxicity, but early, small amorphous intra- and extracellular aggregates of human IAPP were consistently present at the time of beta-cell death and therefore may be the most cytotoxic form of IAPP.
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
Aquino, Christopher, Armour, Duncan, Berman, Judd, Birkemo, Larry S., Carr, Robin A. E., Croom, Dallas K., Dezube, Milana, Dougherty, R. W., Ervin, Gregory N., Grizzle, Mary K., Head, Julie E., Hirst, Gavin C. , James, Michael K. , Johnson, Michael F., Queen, Kennedy L., Rimele, Thomas J., Smith, David Norman , Sugg, Elizabeth E., Miller, Laurence J.

Mayo Clinic

Journal of Medicinal Chemistry | July 26, 2002 | Volume: 39 | Issue: 2 | Pages: 562-569

10.1021/jm950626d | PMID 8558528 Get It

Characterization of Molecular Defects in Isovaleryl-CoA Dehydrogenase in Patients with Isovaleric Acidemia
Mohsen, Al‐Walid , Anderson, Bambi D., Volchenboum, Samuel L. , Battaile, K.P. , Tiffany, Karen, Kim, Jung‐Ja P. , Vockley, Jerry , Roberts, David D.

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 37 | Issue: 28 | Pages: 10325-10335

10.1021/bi973096r | PMID 9665741 Get It

Disease-Associated Mutations in Cytoplasmic Loops 1 and 2 of Cystic Fibrosis Transmembrane Conductance Regulator Impede Processing or Opening of the Channel
Seibert, Fabian S., Mathews, Ceri J., Riordan, John R., Loo, Tip W. , Jia, Yanlin , Hanrahan, John W. , Clarke, David M.

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 36 | Issue: 39 | Pages: 11966-11974

10.1021/bi9712652 | PMID 9305991 Get It

Structure of Human Isovaleryl-CoA Dehydrogenase at 2.6 Å Resolution:  Structural Basis for Substrate Specificity,
Tiffany, Karen, Roberts, David L., Paschke, Rosemary, Mohsen, Al‐Walid , Vockley, Jerry , Kim, Jung‐Ja P. , Roberts, David Leland , Wang, Ming

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 36 | Issue: 28 | Pages: 8455-8464

10.1021/bi970422u | PMID 9214289 Get It

Protonation States of the Chromophore of Denatured Green Fluorescent Proteins Predicted by ab Initio Calculations
Yazal, Jamal El, Prendergast, Franklyn G., Shaw, David E. , Pang, Yuan‐Ping , Pang, Yuan-Ping

Mayo Clinic

Journal of the American Chemical Society | July 26, 2002 | Volume: 122 | Issue: 46 | Pages: 11411-11415

10.1021/ja0008721 Get It

Clinicopathologic Study of Ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV
Boué, Daniel R. , Parham, David M. , Crist, William M., Qualman, Stephen J., Office, from the Intergroup Rhabdomyosarcoma Study Group (IRSG) representing the Children's Cancer Group, the Pediatric Oncology Group,, Anderson, James R., Breitfeld, Richard J., Breneman, John C. , Bridge, Julia A. , Brown, Kenneth L. , Grier, Holcombe E. , Houghton, Peter J. , Link, Michael P., Lobe, Thom L., Maurer, Harold M., Meyer, William H. , Michalski, Jeff M. , Murphy, Sharon, Raney, R. Beverly, Robison, Leslie, Skapek, Stephen X. , Teot, Lisa A., Vietti, Teresa J., Walterhouse, David , Wharam, Mondy, Wiener, Eugene S. , Womer, Richard B. , Webber, Bruce L. , Office, from the Intergroup Rhabdomyosarcoma Study Group (IRSG) representing the Children's Cancer Group, the Pediatric Oncology Group, and the Intergroup Rhabdomyosarcoma Statistical, Anderson, James R., Donaldson, Sarah S. , Hawkins, Douglas S. , Paidas, Charles N. , Pappo, Alberto S. , Sandler, Eric , Smith, Lynn , Sorensen, Poul H. , Spunt, Sheri L. , Triche, Timothy J. , Wolden, Suzanne L.

Mayo Clinic

Pediatric and Developmental Pathology | July 25, 2002 | Volume: 3 | Issue: 3 | Pages: 290-300

10.1007/s100249910039 | PMID 10742419 Get It

Ectomesenchymomas (EM) are rare malignant neoplasms usually consisting of rhabdomyosarcoma (RMS) with a neural component. Only 21 cases have been previously reported. Here we extend the clinicopathologic spectrum of EM by describing our findings in 15 cases. Only 5 patients were infants; 10 were ≤3 years old and 5 were ≥6 years old. No male predilection was observed; 7 were female. The originating institutional diagnoses were; RMS (12), undifferentiated sarcoma (1), or EM (2), suggesting underdiagnosis of this entity. The primary tumor sites included external genital (5), pelvis/abdomen (6), head and neck (3), and extremity (1). The size of the primary neoplasm was usually ≥5 cm at diagnosis but dissemination only occurred in a minority. Local infiltration was not uncommon. These neoplasms were typically multilobate, thinly encapsulated, hemorrhagic, and necrotic. Light microscopic features were highly variable, but embryonal RMS with scattered or clustered ganglion cells, often in lacunae, was characteristic. In some cases, primitive neuroblastic or neuroectodermal areas were found and/or a component of alveolar RMS was seen. Focal anaplasia was occasionally observed. Mitotic activity appears higher than previously appreciated and some necrosis was invariably present. Electron microscopy was performed in 11 cases, which confirmed skeletal muscle ± neural differentiation. Cytogenetic studies performed in five cases revealed no specific abnormality. Monoclonal neuron-specific enolase was the best marker of ganglion cells and primitive neural elements. MIC-2 (CD99) membrane expression was not definitively present in any of the six cases examined. A number of the above parameters appear to be of some prognostic significance, but overall, these neoplasms appear to have a similar outcome as would be predicted for their RMS element alone (exclusive of any neural component), with respect to the RMS subtype, age of the patient, and anatomic location of the neoplasm.
Intergroup Rhabdomyosarcoma Study: Update for Pathologists
Qualman, Stephen J., Coffin, Cheryl M., Newton, William A., Hojo, Hiroshi, Parham, David M. , Crist, William M., Triche, Timothy J.

Mayo Clinic

Pediatric and Developmental Pathology | July 25, 2002 | Volume: 1 | Issue: 6 | Pages: 550-561

10.1007/s100249900076 | PMID 9724344 Get It

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood, and 75% of such cases in the United States are reviewed at the Pathology Center for the Intergroup Rhabdomyosarcoma Study Group (IRSG). The first four generations of IRSG therapeutic trials (IRS I–IV) and supportive pathologic studies have generated a new International Classification of Rhabdomyosarcoma (ICR) that offers new morphologic concepts to the practicing pathologist. The objective of this report is to clearly define emerging histopathologic categories of RMS as defined by the ICR, and to emphasize correlative immunohistochemical or molecular studies. Emerging ICR variants of RMS place the patient in widely divergent prognostic categories (superior, botryoid or spindle cell variants; poor, solid alveolar or diffusely anaplastic variants). The cardinal histopathologic features of the ICR combined with results of studies of fusion genes seen with t(1;13) and t(2;13) will help delineate therapeutic subgroups of RMS for the fifth generation (IRS V) of IRSG studies. Consequently, it is imperative for the practicing pathologist to be familiar with the practical workup and diagnosis of RMS in childhood.